# Dydrogesterone Versus GnRH Antagonist in Poor Responders Undergoing Double Ovarian Stimulation

> **NCT06212102** · PHASE2 · RECRUITING · sponsor: **Bedaya Hospital** · enrollment: 120 (estimated)

## Conditions studied

- Infertility

## Interventions

- **DRUG:** Progestin primed ovarian stimulation
- **DRUG:** GnRH antagonist

## Key facts

- **NCT ID:** NCT06212102
- **Lead sponsor:** Bedaya Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-05-08
- **Primary completion:** 2027-03-01
- **Final completion:** 2027-08-01
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2026-05-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06212102

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06212102, "Dydrogesterone Versus GnRH Antagonist in Poor Responders Undergoing Double Ovarian Stimulation". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT06212102. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*